+43-123-13-985|info@ces.b2sg.org

Senior Scientific Researcher – Molecular Biology

By | 2017-05-04T18:27:01+00:00 May 4th, 2017|

The Position We are seeking a Senior Scientific Researcher in the Department of Molecular Biology to assist with the development of an advanced cell-based molecular genetics platform. She/he will utilize and create diverse nucleic-acid-based technologies for targeted manipulation of primary and immortalized cells, with the ultimate goal of improving upon in vitro disease models and [...]

Cancer Epigenetics Database, Experimental section: KDMi are in!

By | 2017-05-19T11:28:44+00:00 November 7th, 2016|News|

The experimental section of the Cancer Epigenetics Drug Database has been expanded to now include a fourth class of epigenetics-targeting drugs: the inhibitors of histone (lysine) demethylases or KDMi. This database currently includes data on 9 KDMi and 61 cancer cell lines. Together, the experimental section of the Cancer Epigenetics Drug Database now includes more [...]

Update on the Cancer Epigenetics Database, Experimental section

By | 2017-05-19T11:28:44+00:00 August 19th, 2016|News|

We at the Cancer Epigenetics Society have lately focused our efforts on expanding the experimental datasets of the Cancer Epigenetics Drug Database with emphasis on three large classes of epigenetics-targeting drugs. These are the inhibitors of the DNA methyltransferases (DNMTi), histone deacetylases (HDACi), and histone methyltransferases (HMTi). Together, the three datasets include more than 2,500 [...]